UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of CYP2C19 Pharmacogenetic Polymorphism on Proton Pump Inhibitor-based Therapies

DRUG METABOLISM AND PHARMACOKINETICS, 2005, Vol.20 (3), p.153-167

2005

Volltextzugriff (PDF)

Role of renin-angiotensin system in gastric oncogenesis

Journal of gastroenterology and hepatology, 2012-03, Vol.27 (3), p.442-451

2012

Volltextzugriff (PDF)

Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer

Journal of gastroenterology and hepatology, 2007-01, Vol.22 (1), p.51-59

2007

Volltextzugriff (PDF)

Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects

Journal of gastroenterology and hepatology, 2007-09, Vol.22 (9), p.1443-1449

2007

Volltextzugriff (PDF)

Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy

European journal of clinical pharmacology, 2007-08, Vol.63 (8), p.743-749

2007

Volltextzugriff (PDF)

潰瘍性大腸炎を合併した2型自己免疫性膵炎2症例の検討

日本消化器病学会雑誌, 2021/12/10, Vol.118(12), pp.1151-1159

2021

Volltextzugriff (PDF)

Relationship Between Low-Dose Aspirin-Induced Gastric Mucosal Injury and Intragastric pH in Healthy Volunteers

Digestive diseases and sciences, 2010-06, Vol.55 (6), p.1627-1636

2010

Volltextzugriff (PDF)

Influences of Chymase and Angiotensin I-Converting Enzyme Gene Polymorphisms on Gastric Cancer Risks in Japan

Cancer epidemiology, biomarkers & prevention, 2006-10, Vol.15 (10), p.1929-1934

2006

Volltextzugriff (PDF)

Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole

Clinical pharmacology and therapeutics, 2002-10, Vol.72 (4), p.453-460

2002

Volltextzugriff (PDF)

Outcome of Radiotherapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Refractory to Helicobacter Pylori Eradication Therapy

Internal Medicine, 2006, Vol.45(6), pp.405-409

2006

Volltextzugriff (PDF)

Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics

Expert opinion on pharmacotherapy, 2007-11, Vol.8 (16), p.2701-2717

2007

Volltextzugriff (PDF)

Sa1187 - Effects of Dosing Strategy of Amoxicillin on Eradication Rates of Helicobacter Pylori with Amoxicillin-Based Triple Therapy

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S247-S247

2017

Volltextzugriff (PDF)

A case of IgG4-related autoimmune hepatitis that was difficult to diagnosis

Kanzo, 2022/02/01, Vol.63(2), pp.43-50

2022

Volltextzugriff (PDF)

A case of IgG4-related autoimmune hepatitis that was difficult to diagnosis

Kanzo, 2022-02, Vol.63 (2), p.43-50

2022

Volltextzugriff (PDF)

Judgment of eradication of H. pylori based on percent changes in serum pepsinogens

Nippon Shokakibyo Gakkai Zasshi, 2013, Vol.110(2), pp.210-217

2013

Volltextzugriff (PDF)

CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor

Pharmacogenomics, 2007-09, Vol.8 (9), p.1199-1210

2007

Volltextzugriff (PDF)

Effects of Dosing Strategy of Amoxicillin on Eradication Rates of Helicobacter Pylori with Amoxicillin-Based Triple Therapy

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S247-S247

2017

Volltextzugriff (PDF)

Two patients with all-trans retinoic acid-resistant acute promyelocytic leukemia treated successfully with gemtuzumab ozogamicin as a single agent

International journal of hematology, 2005-12, Vol.82 (5), p.445-448

2005

Volltextzugriff (PDF)

Individualized Therapy for Gastroesophageal Reflux Disease: Potential Impact of Pharmacogenetic Testing based on CYP2C19

Molecular diagnosis & therapy, 2012-08, Vol.16 (4), p.223-234

2012

Volltextzugriff (PDF)

Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan

Gastroenterology (New York, N.Y. 1943), 2002-07, Vol.123 (1), p.92-105

2002

Volltextzugriff (PDF)

676 - Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as First-Line Triple Therapy for Helicobacter Pylori Eradication: A Systematic Review and Meta-Analysis

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S151-S152

2017

Volltextzugriff (PDF)

Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as First-Line Triple Therapy for Helicobacter Pylori Eradication: A Systematic Review and Meta-Analysis

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S151-S152

2017

Volltextzugriff (PDF)

Pharmacogenomics of proton pump inhibitors

Pharmacogenomics, 2004-03, Vol.5 (2), p.181-202

2004

Volltextzugriff (PDF)

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

Clinical pharmacology and therapeutics, 2001-03, Vol.69 (3), p.158-168

2001

Volltextzugriff (PDF)

Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status

Clinical pharmacology and therapeutics, 2004-10, Vol.76 (4), p.290-301

2004

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Englisch
(65)
Japanisch
(35)

Erscheinungsjahr

n.n

Thema

Humans
(40)
Science & Technology
(35)
Life Sciences & Biomedicine
(32)
Helicobacter Pylori
(23)
Male
(21)
Cytochrome P-450 Cyp2c19
(19)
Female
(18)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Middle Aged
(17)
Aryl Hydrocarbon Hydroxylases - Genetics
(16)
Pharmacology & Pharmacy
(16)
Helicobacter Infections - Drug Therapy
(15)
Mixed Function Oxygenases - Genetics
(15)
Genotype
(14)
Polymorphism, Genetic
(14)
Aged
(11)
Drug Therapy, Combination
(11)
Gastroenterology & Hepatology
(11)
Lansoprazole
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Influence of CYP2C19 Pharmacogenetic Polymorphism on Proton Pump Inhibitor-based Therapies

Role of renin-angiotensin system in gastric oncogenesis

Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer

Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects

Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy

潰瘍性大腸炎を合併した2型自己免疫性膵炎2症例の検討

Relationship Between Low-Dose Aspirin-Induced Gastric Mucosal Injury and Intragastric pH in Healthy Volunteers

Influences of Chymase and Angiotensin I-Converting Enzyme Gene Polymorphisms on Gastric Cancer Risks in Japan

Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole

Outcome of Radiotherapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Refractory to Helicobacter Pylori Eradication Therapy

Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics

Sa1187 - Effects of Dosing Strategy of Amoxicillin on Eradication Rates of Helicobacter Pylori with Amoxicillin-Based Triple Therapy

A case of IgG4-related autoimmune hepatitis that was difficult to diagnosis

A case of IgG4-related autoimmune hepatitis that was difficult to diagnosis

Judgment of eradication of H. pylori based on percent changes in serum pepsinogens

CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor

Effects of Dosing Strategy of Amoxicillin on Eradication Rates of Helicobacter Pylori with Amoxicillin-Based Triple Therapy

Two patients with all-trans retinoic acid-resistant acute promyelocytic leukemia treated successfully with gemtuzumab ozogamicin as a single agent

Individualized Therapy for Gastroesophageal Reflux Disease: Potential Impact of Pharmacogenetic Testing based on CYP2C19

Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan

676 - Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as First-Line Triple Therapy for Helicobacter Pylori Eradication: A Systematic Review and Meta-Analysis

Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as First-Line Triple Therapy for Helicobacter Pylori Eradication: A Systematic Review and Meta-Analysis

Pharmacogenomics of proton pump inhibitors

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status

Aktive Filter

Suchergebnisse filtern